Fenomen nochnogo kislotnogo proryva na fone lecheniya ingibitorami protonnoy pompy i ego terapevticheskaya korrektsiya
- Authors: Bulgakov S.A1
-
Affiliations:
- Issue: No 13 (2012)
- Pages: 62-66
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279746
- ID: 279746
Cite item
Open Access
Access granted
Abstract
The article discusses the phenomenon of nocturnal acid breakthrough (NAB), which arises against the background of the use of proton pump inhibitors (PPIs) for the treatment of acid-related disorders, especially gastroesophageal reflux disease. Definition of the phenomenon is presented, the mechanism of its development and treatment options are considered. The potentials for the use of PPIs with accelerated antisecretory effect in the treatment of NAB and their difference from omeprazole with delayed release are discussed. The characteristics of the new IPP Omez® Insta are presented, and its effectiveness in the treatment of acid-related disorders and NAB is demonstrated.
Full Text
References
- Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux diseases management - the Genval Workshop report. Gut 1999;44:1-16.
- Лазебник Л.Б., Васильев Ю.В., Мананников И. В. Изжога как один из основных критериев ГЭРБ (результаты одного эпидемиологического исследования) // Экспер. клин. гастроэнтер. 2004. № 1. С. 164-65.
- Лазебник Л.Б., Бордин Д.С., Машарова А.А. Общество против изжоги. ЦНИИ гастроэнтерологии. М., С. 6.
- Moayyedi P, Talley N. Gastroesophageal reflux disease. Lancet 2006;367:2086-100.
- Вялов С.С., Чорбинская С.А. Гастроэзофагорефлюксная болезнь (ГЭРБ): диагностика, лечение и профилактика. Методические рекомендации. № 338-12/23. М., 2011. 16 с.
- Krause-Anderson S, Wallin L, Matsen T. Acid gastroesophageal reflux and oesophageal pressure activity during postprandial and nocturnal periods: a study in subjects with and without pathological acid gastro-oesopha-geal reflux. Scand J Gastroenterol 1987;22: 926-30.
- Farup C, Kleinman L, Sloan S, et al. The impact of noctural symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001; 161:45-52.
- Пасечников В.Д., Пасечников Д.В. Клиническое значение феномена ночного кислотного прорыва при применении ингибиторов протонной помпы// Фарматека 2004. №13(90). С. 28-32.
- Van Pinxteren B, Numans ME, Bonis PA, et al. Short term treatment with proton pump inhibitors, H2RAs and prokinetics for gastrooesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2004;3:CD 002095.
- Janson C, Gislason T, De Backer W, et al. Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma. Eur Respir J 1996;9 2132-38.
- Tutuian R, Castell D. Nocturnal acid breakthrough - approach to management. Medscape General Medicine 2004;6(4):11.
- Hammer J, Schmidt B. Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough. Aliment Pharmacol Ther 2004;19:1105-10.
- Hatlebakk J, Katz P, Kuo B, et al. Nocturnal gastric acidity and acid breakthrough on different regiment of omeprazole 40 mg daily. Aliment Pharmacol Ther 1998;12:1235-40.
- Peghini P, Katz P, Castell D. Ranitidine controls nocturnal acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 1998;115:1335-39.
- Paolo L, Peghini P, Katz PO, et al. Ranitidine controls nocturnal gastic acid breakthrough on omeprazole: a controlled study in normal subjects. Medscape Gastroenterology 1999;1.
- Ducrotte P, Guillemot F, Elouaer-Blanc L, et al. Comparison of omeprazole and famotidine on oesophageal pH in patients with moderate to severe oesophagitis: a cross-over study. Am J Gastroenterol 1994;89:717-21.
- Castell D, Bagin R, Goldlust B, et al. Comparison on effects of immediate-release omeprazole and delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;21(12): 1467-74.
- Katz P, Koch F, Ballard E, et al. Comparison on effects of immediate-release omeprazole oral suspension, delayed-release lansoprasole capsules and delayed-release esomeprasole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms. Aliment Pharmacol Ther 2007;25(2):197-205.
- Package insert: Immediate-release omeprazole [(IR-OME) zegerid power for oral suspension; Santarus Inc, San Diego, CA, USA]. December, 2004.
- Саблин О.А. Ледовская А.А. Новые возможности антисекреторной терапии гастроэзофагеальной рефлюксной болезни// Экспер. и клин. гастроэнтер. 2012. № 6.
Supplementary files
